New Jersey’s dynamic life sciences ecosystem is in the national spotlight once again, featured in Bio Business magazine’s article, entitled Growing in the Garden State: Here’s Why Big Pharma has Put Down Roots in New Jersey. The editorial touts New Jersey as “…fertile ground for biotechnology and pharmaceutical companies looking to move from proof of concept to production…the State has become a lodestone for big bio business.”
This week’s edition of the BioLines Weekender continues to be chock full of stories highlighting the innovation taking place in the State, including progress in numerous clinical trials, drug development, corporate partnering and funding.
Looking for new licensing agreements, business opportunities or partnerships? Attend BioNJ’s Sixth Annual International BioPartnering Conference taking place next Thursday, May 26. From Keynote presentations, plenary sessions and company presentations to partnering, networking and exhibits, there’ll be something for everyone. Hope to see you there. Call if we can support you in any way.
Click here to read this week’s Weekender.